- Report
- February 2022
- 84 Pages
Global
From €3200EUR$3,710USD£2,774GBP
- Report
- June 2026
- 160 Pages
Global
From €2586EUR$2,799USD£2,166GBP
€3233EUR$3,499USD£2,708GBP
- Report
- October 2024
- 89 Pages
Global
From €3500EUR$4,058USD£3,034GBP
- Report
- February 2024
- 104 Pages
Global
From €3500EUR$4,058USD£3,034GBP
- Report
- December 2023
- 100 Pages
Africa
From €1848EUR$2,000USD£1,548GBP
- Report
- May 2023
- 80 Pages
Russia
From €1386EUR$1,500USD£1,161GBP
- Report
- December 2025
- 26 Pages
Brazil
From €995EUR$1,154USD£863GBP
- Report
- December 2025
- 20 Pages
Algeria
From €995EUR$1,154USD£863GBP
- Report
- November 2025
- 24 Pages
Philippines
From €995EUR$1,154USD£863GBP
- Report
- November 2025
- 27 Pages
New Zealand
From €995EUR$1,154USD£863GBP
- Report
- November 2025
- 19 Pages
Tunisia
From €995EUR$1,154USD£863GBP
- Report
- November 2025
- 24 Pages
Nigeria
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 21 Pages
Kenya
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 23 Pages
Singapore
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 22 Pages
Ireland
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 24 Pages
Spain
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 26 Pages
South Africa
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 22 Pages
North Macedonia
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 22 Pages
Indonesia
From €995EUR$1,154USD£863GBP
- Report
- October 2025
- 25 Pages
Thailand
From €995EUR$1,154USD£863GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more